Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know

Purpose: Presymptomatic testing for susceptibility to genetic prion diseases is often delivered in difficult circumstances, as the index case is often dying when a genetic diagnosis is obtained. Since test requests in these diseases are very rare, the factors underlying decisions of relatives to be...

Full description

Bibliographic Details
Main Authors: Mathias Schwartz, Jean-Philippe Brandel, Marie Lise Babonneau, Christilla Boucher, Elodie Schaerer, Stephane Haik, Jean Louis Laplanche, Marcela Gargiulo, Alexandra Durr
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2019.00895/full
id doaj-330dc115026841b89b1f3fb41726b537
record_format Article
spelling doaj-330dc115026841b89b1f3fb41726b5372020-11-25T02:45:42ZengFrontiers Media S.A.Frontiers in Genetics1664-80212019-09-011010.3389/fgene.2019.00895462246Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to KnowMathias Schwartz0Jean-Philippe Brandel1Jean-Philippe Brandel2Marie Lise Babonneau3Marie Lise Babonneau4Christilla Boucher5Elodie Schaerer6Stephane Haik7Stephane Haik8Jean Louis Laplanche9Jean Louis Laplanche10Marcela Gargiulo11Marcela Gargiulo12Marcela Gargiulo13Alexandra Durr14Alexandra Durr15APHP, Department of Genetics, University Hospital Pitié-Salpêtrière, Paris, FranceCellule nationale de référence des maladies de Creutzfeldt-Jakob, APHP, University Hospital Pitié-Salpêtrière, Paris, FranceInstitut du Cerveau et de la Moelle épinière (ICM), AP-HP, Inserm, CNRS, University Hospital Pitié-Salpêtrière, Sorbonne Université, Paris, FranceAPHP, Department of Genetics, University Hospital Pitié-Salpêtrière, Paris, FranceCellule nationale de référence des maladies de Creutzfeldt-Jakob, APHP, University Hospital Pitié-Salpêtrière, Paris, FranceAPHP, Department of Genetics, University Hospital Pitié-Salpêtrière, Paris, FranceAPHP, Department of Genetics, University Hospital Pitié-Salpêtrière, Paris, FranceCellule nationale de référence des maladies de Creutzfeldt-Jakob, APHP, University Hospital Pitié-Salpêtrière, Paris, FranceInstitut du Cerveau et de la Moelle épinière (ICM), AP-HP, Inserm, CNRS, University Hospital Pitié-Salpêtrière, Sorbonne Université, Paris, FranceCellule nationale de référence des maladies de Creutzfeldt-Jakob, APHP, University Hospital Pitié-Salpêtrière, Paris, FranceDépartement de Biochimie et biologie moléculaire, Lariboisière Hospital, Paris, FranceAPHP, Department of Genetics, University Hospital Pitié-Salpêtrière, Paris, FranceLaboratoire de Psychologie Clinique et Psychopathologie, Institut de Psychologie, Université Paris Descartes, Sorbonne Paris Cité, Paris, FranceInstitut of Myologie, University Hospital Pitié-Salpêtrière, Paris, FranceAPHP, Department of Genetics, University Hospital Pitié-Salpêtrière, Paris, FranceInstitut du Cerveau et de la Moelle épinière (ICM), AP-HP, Inserm, CNRS, University Hospital Pitié-Salpêtrière, Sorbonne Université, Paris, FrancePurpose: Presymptomatic testing for susceptibility to genetic prion diseases is often delivered in difficult circumstances, as the index case is often dying when a genetic diagnosis is obtained. Since test requests in these diseases are very rare, the factors underlying decisions of relatives to be tested or not and the long-term psychological consequences are not reported.Methods: We contacted subjects who had consulted between 2004 and 2017 because a relative carried a pathological PRNP variant. Standardized psychological scales and semistructured interviews were proposed.Results: We did contact 19 of the 30 subjects who had consulted: 6 of 10 who did not undergo testing, 10 of 12 noncarriers, and 3 of 8 mutation carriers. Anxiety rates were high and similar between noncarriers and untested subjects.Conclusions: Living in a family with inherited prion disease produced psychological burden, regardless of the decision to undergo testing and its results. Decisions in favor of being testing did not allow relief of anxiety about the family disease. The dilemmatic decision not to know remained a burden to be coped with. Genetic counseling procedures should take into account all these situations, even that of noncarriers and that of untested.https://www.frontiersin.org/article/10.3389/fgene.2019.00895/fullPRNPpresymptomatic testingprionpsychological scalesanxiety
collection DOAJ
language English
format Article
sources DOAJ
author Mathias Schwartz
Jean-Philippe Brandel
Jean-Philippe Brandel
Marie Lise Babonneau
Marie Lise Babonneau
Christilla Boucher
Elodie Schaerer
Stephane Haik
Stephane Haik
Jean Louis Laplanche
Jean Louis Laplanche
Marcela Gargiulo
Marcela Gargiulo
Marcela Gargiulo
Alexandra Durr
Alexandra Durr
spellingShingle Mathias Schwartz
Jean-Philippe Brandel
Jean-Philippe Brandel
Marie Lise Babonneau
Marie Lise Babonneau
Christilla Boucher
Elodie Schaerer
Stephane Haik
Stephane Haik
Jean Louis Laplanche
Jean Louis Laplanche
Marcela Gargiulo
Marcela Gargiulo
Marcela Gargiulo
Alexandra Durr
Alexandra Durr
Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know
Frontiers in Genetics
PRNP
presymptomatic testing
prion
psychological scales
anxiety
author_facet Mathias Schwartz
Jean-Philippe Brandel
Jean-Philippe Brandel
Marie Lise Babonneau
Marie Lise Babonneau
Christilla Boucher
Elodie Schaerer
Stephane Haik
Stephane Haik
Jean Louis Laplanche
Jean Louis Laplanche
Marcela Gargiulo
Marcela Gargiulo
Marcela Gargiulo
Alexandra Durr
Alexandra Durr
author_sort Mathias Schwartz
title Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know
title_short Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know
title_full Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know
title_fullStr Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know
title_full_unstemmed Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know
title_sort genetic testing in prion disease: psychological consequences of the decisions to know or not to know
publisher Frontiers Media S.A.
series Frontiers in Genetics
issn 1664-8021
publishDate 2019-09-01
description Purpose: Presymptomatic testing for susceptibility to genetic prion diseases is often delivered in difficult circumstances, as the index case is often dying when a genetic diagnosis is obtained. Since test requests in these diseases are very rare, the factors underlying decisions of relatives to be tested or not and the long-term psychological consequences are not reported.Methods: We contacted subjects who had consulted between 2004 and 2017 because a relative carried a pathological PRNP variant. Standardized psychological scales and semistructured interviews were proposed.Results: We did contact 19 of the 30 subjects who had consulted: 6 of 10 who did not undergo testing, 10 of 12 noncarriers, and 3 of 8 mutation carriers. Anxiety rates were high and similar between noncarriers and untested subjects.Conclusions: Living in a family with inherited prion disease produced psychological burden, regardless of the decision to undergo testing and its results. Decisions in favor of being testing did not allow relief of anxiety about the family disease. The dilemmatic decision not to know remained a burden to be coped with. Genetic counseling procedures should take into account all these situations, even that of noncarriers and that of untested.
topic PRNP
presymptomatic testing
prion
psychological scales
anxiety
url https://www.frontiersin.org/article/10.3389/fgene.2019.00895/full
work_keys_str_mv AT mathiasschwartz genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT jeanphilippebrandel genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT jeanphilippebrandel genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT marielisebabonneau genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT marielisebabonneau genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT christillaboucher genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT elodieschaerer genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT stephanehaik genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT stephanehaik genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT jeanlouislaplanche genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT jeanlouislaplanche genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT marcelagargiulo genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT marcelagargiulo genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT marcelagargiulo genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT alexandradurr genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
AT alexandradurr genetictestinginpriondiseasepsychologicalconsequencesofthedecisionstoknowornottoknow
_version_ 1724760933183520768